- Home
- FLNC vs AMLX Comparison
FLNC vs AMLX Comparison
Compare FLNC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNC | AMLX |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FLNC | AMLX |
|---|---|---|
| Price | $21.13 | $14.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 9 |
| Target Price | $15.71 | ★ $21.56 |
| AVG Volume (30 Days) | ★ 9.8M | 1.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,262,830,000.00 | $380,786,000.00 |
| Revenue This Year | $51.23 | N/A |
| Revenue Next Year | $21.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $4.40 | $4.64 |
| 52 Week High | $33.51 | $18.61 |
Technical Indicators
Market Signals| Indicator | FLNC | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.00 | 34.97 |
| Support Level | $13.05 | $13.57 |
| Resistance Level | $22.93 | $15.37 |
| Average True Range (ATR) | 2.00 | 0.85 |
| MACD | 1.07 | -0.33 |
| Stochastic Oscillator | 61.20 | 2.16 |
Price Performance
Historical ComparisonAbout FLNC Fluence Energy Inc.
Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.